Related Experiment Video
Updated: May 28, 2026

10:43
Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
Published on: December 3, 2010
Mammalian multidrug-resistance proteins (MRPs)
Andrew J Slot1, Steven V Molinski, Susan P C Cole
1Division of Cancer Biology and Genetics, Queen's University Cancer Research Institute, Kingston, ON, Canada, K7L 3N6.
Essays in Biochemistry
|October 5, 2011
Summary
The human ABC superfamily
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- The human ABC superfamily includes nine proteins known as multidrug-resistance proteins (MRPs).
- These transporters exhibit structural variations, including 'short' and 'long' forms, influencing their function.
- While some MRPs transport drugs and endogenous compounds, others have unknown in vivo substrates.
Purpose of the Study:
- To elucidate the diverse roles and substrate specificities of the nine MRP/ABCC transporters.
- To highlight the structural differences and tissue distribution patterns of these transporters.
- To underscore the importance of MRPs in cellular transport and physiological processes.
Main Methods:
- Comparative analysis of MRP/ABCC transporter structures.
- Review of studies on substrate specificity and tissue distribution.
- Investigation of gene-knockout mouse models to identify in vivo substrates.
Main Results:
- MRP/ABCC transporters exhibit distinct structural domains ('short' vs. 'long' forms).
- Transport substrates include exogenous drug metabolites and endogenous signaling molecules.
- Tissue distribution and membrane localization vary, contributing to unique functions.
- In vivo substrates for MRP5, MRP7, ABCC6, and ABCC12 remain largely unidentified.
Conclusions:
- Structural and functional diversity among MRP/ABCC transporters dictates their specific roles.
- Understanding MRP substrate specificity is crucial for pharmacology and physiology.
- Further research is needed to fully characterize the in vivo functions of all nine MRPs.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Carrier-Mediated Transport
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
ABC Transporters: Exporter
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Multi-pass Transmembrane Proteins and β-barrels
In multi-pass transmembrane proteins, the polypeptide chain crosses the membrane more than once. The transmembrane polypeptide chain either forms an α-helix or β-strand structure. α-Helix containing multi-pass transmembrane proteins are ubiquitous, whereas β-strand containing ones are mainly found in gram-negative bacteria, mitochondria, and chloroplasts.
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as G-protein-linked receptors (GPCRs) and...
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as G-protein-linked receptors (GPCRs) and...

